| name | clinical-trial-protocol-disclaimers |
| description | Sub-skill of clinical-trial-protocol: Disclaimers. |
| version | 1.0.0 |
| category | science |
| type | reference |
| scripts_exempt | true |
Disclaimers
Disclaimers
IMPORTANT: This protocol generation tool provides preliminary clinical study protocol based on NIH/FDA guidelines and similar trials. It does NOT constitute:
- Official FDA or IRB determination or approval
- Medical, legal, or regulatory advice
- Substitute for professional biostatistician review
- Substitute for FDA Pre-Submission meeting
- Guarantee of regulatory or clinical success
REQUIRED before proceeding with clinical study:
- Biostatistician review and sample size validation
- FDA Pre-Submission meeting (Q-Submission for devices, Pre-IND for drugs)
- IRB review and approval
- Clinical expert and regulatory consultant engagement
- Legal review of protocol and informed consent
- Site investigator review and input
- Sponsor completion of all [TBD] items in protocol
PROFESSIONAL CONSULTATION STRONGLY RECOMMENDED
Clinical trial protocols are complex, high-stakes documents requiring expertise across multiple disciplines. Professional consultation with clinical trial experts, biostatisticians, and regulatory affairs specialists is essential before proceeding with clinical study planning.
